Zhongzhu Healthcare HoldingLtd Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Bo Anna Wang

Geschäftsführender

CN¥1.2m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	5.5yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Bo Anna Wang (61 yo)

no data

Amtszeit

CN¥1,200,000

Vergütung

Ms. Bo Anna Wang serves as President of Zhongzhu Healthcare Holding Co.,Ltd.

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Bao Long Qiao	VP & Director	5.5yrs	CN¥530.00k	keine Daten
Jige Ye	Chairman	5.5yrs	CN¥1.43m	0.17% CN¥ 4.4m
Dong Mei Huang	Member of the Supervisory Board	no data	keine Daten	keine Daten
Jian Li	Member of the Supervisory Board	no data	keine Daten	keine Daten
Yi Bin Zeng	Independent Director	5.5yrs	CN¥96.00k	keine Daten
Qin Xu	Employee Supervisor	4.1yrs	keine Daten	keine Daten
Lang Chen	Independent Director	no data	CN¥96.00k	keine Daten

5.5yrs

Durchschnittliche Betriebszugehörigkeit

49yo

Durchschnittliches Alter

Erfahrener Vorstand: 600568Die Vorstandsmitglieder gelten als erfahren (5.1 Jahre durchschnittliche Amtszeit).

Zhongzhu Healthcare HoldingLtd Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Insufficient new directors

Recent updates

Zhongzhu Healthcare Holding Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report First Half, 2024 Results on Aug 27, 2024

First quarter 2024 earnings released: CN¥0.011 loss per share (vs CN¥0.014 loss in 1Q 2023)

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.40 loss in FY 2022)

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Fiscal Year 2023 Results on Apr 17, 2024

Third quarter 2023 earnings released: CN¥0.008 loss per share (vs CN¥0.009 loss in 3Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.011 loss in 2Q 2022)

Full year 2022 earnings released: CN¥0.40 loss per share (vs CN¥0.11 loss in FY 2021)

Third quarter 2022 earnings released: CN¥0.009 loss per share (vs CN¥0.008 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.011 loss per share (vs CN¥0.012 loss in 2Q 2021)

First quarter 2022 earnings released: CN¥0.002 loss per share (vs CN¥0.012 loss in 1Q 2021)

Third quarter 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.005 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.012 loss per share (vs CN¥0.003 loss in 2Q 2020)

Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. signed the share transfer agreement to acquire a 51% stake in Zhongzhu Zhongke Stem Cell Gene Technology Co., Ltd. from Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) for CNY 3 million.

Zeng Yamei won the bid and acquired 2.9% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from Zhuhai Zhongzhu Group Co., Ltd. for CNY 104.2 million.

Full year 2020 earnings released: EPS CN¥0.002 (vs CN¥0.18 loss in FY 2019)

Zhongzhu Healthcare's Shareholders to Sell 5.14% Stakes in the Company

New 90-day low: CN¥1.53

An unknown technology firm acquired 6.4% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568).

Xiao Feiying completed the acquisition of 6.26% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from the group of sellers.

Third quarter earnings released

Zhuhai Zhongzhu Co Ltd. agreed to be acquire the remaining 70.03% stake in Hubei Qianjiang Pharmaceutical Co., Ltd. (SHSE: 600568) in a reverse merger transaction .

First half earnings released

New 90-day high - CN¥1.50

Zhongzhu Healthcare Holding Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020